nyulangone.org
Jun 16, 2025, 07:06
DNA Differences May Explain Why Some Melanoma Patients Don’t Respond to Immunotherapy – CRI
Cancer Research Institute (CRI) shared a post on LinkedIn:
“In a new study, researchers, including CRI Scientific Advisory Council member Dr. Thomas Gajewski of the University of Chicago, observed that patients with metastatic melanoma who did not respond to immune checkpoint inhibitors had DNA with differences not found in the DNA of those who did respond. NYU Langone Health describes how these findings ‘help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do not respond to the latest cancer treatments.’ Discover.”
More posts featuring CRI.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 27, 2025, 16:53
Jul 27, 2025, 16:04
Jul 27, 2025, 15:38
Jul 27, 2025, 15:14